West Pharmaceutical Services, Inc.WSTNYSE
Loading
Cash Generation ExpandingExpanding
Percentile Rank100
3Y CAGR+2.2%
5Y CAGR+9.5%
Year-over-Year Change
Operating cash flow minus capital expenditures
3Y CAGR
+2.2%/yr
vs +24.3%/yr prior
5Y CAGR
+9.5%/yr
Recent deceleration
Acceleration
-22.1pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.6x
Solid growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $468.90M | +69.6% |
| 2024 | $276.40M | -33.3% |
| 2023 | $414.50M | -5.7% |
| 2022 | $439.40M | +32.9% |
| 2021 | $330.60M | +10.9% |
| 2020 | $298.10M | +23.8% |
| 2019 | $240.80M | +30.9% |
| 2018 | $183.90M | +38.8% |
| 2017 | $132.50M | +169.3% |
| 2016 | $49.20M | - |